Analysis of the prognostic significance of PDIA5 in different types of gliomas under the 2016 WHO classification of CNS tumors demonstrated that patients with low PDIA5 expression experienced longer OS regardless of the subtypes (Supplementary Figures S3J–R). Here, PDIA5 is linked to central nervous system cancer.